Product Specifications
| Product name (EN) | Trerief (Zonisamide) |
|---|---|
| Japanese name (JP) | ✔️ 动作迟缓 トレリーフOD錠 帕金森药 佐尼沙胺口崩片 |
| Chinese name (ZH) | 唑尼沙胺口崩片 |
| Active ingredient (INN) | Zonisamide |
| Strength | 25 mg / 25 mg / 50 mg |
| Dosage form | Orally disintegrating tablet |
| Pack / presentation | Confirmed on inquiry |
| Therapeutic area | Central nervous system / psychiatry |
| Product type | Prescription-only medicine (医療用医薬品 / ethical drug) |
| Country of origin | Japan |
| Manufacturer / MAH | Provided on inquiry |
| SKU | TSU-RX-0049 |
About this product
Trerief (Zonisamide) (✔️ 动作迟缓 トレリーフOD錠 帕金森药 佐尼沙胺口崩片) is a Japanese ethical, prescription-only medicine — 医療用医薬品 — containing the active ingredient Zonisamide, in the central nervous system / psychiatry therapeutic area.
Composition
Active ingredient: Zonisamide. Excipients, full quantitative composition and storage conditions follow the product’s official Japanese package insert (添付文書), available after qualification review.
Official Japanese documentation
This page does not provide prescribing or dosing advice to the public. Under Japan’s Pharmaceuticals and Medical Devices Act (薬機法), the approved indications (効能・効果) and dosage & administration (用法・用量) of prescription medicines are not advertised to the general public; the official Japanese package insert (添付文書) and approved prescribing information are available after qualification review.
Sourcing & export
Tsubaki Trading (Tokyo, Japan) sources authentic Japanese-market product through regulated domestic channels and supports export and export-agency (輸出代行) fulfilment. Product documentation, package inserts, and available regulatory/quality information can be provided to qualified buyers to support import and registration. Minimum order quantities, lead times, and incoterms are confirmed per order.
